SCHEMBL23920645

SCHEMBL23920645

CN1C[C@H](C(=O)NC2CCCCC2)Oc2ccc(Cl)cc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.72
CYP3A4 P08684 3/20 0.72
CYP2C9 P11712 3/20 0.72
CYP2C19 P33261 3/20 0.72
ALDH1A1 P00352 3/20 0.72
CYP2D6 P10635 1/20 0.72
LMNA P02545 2/20 0.57
TP53 P04637 2/20 0.57
MAPT P10636 2/20 0.57
GAA P10253 1/20 0.57
KDM4E B2RXH2 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HPGD P15428 1/20 0.48
KMT2A Q03164 1/20 0.48
POLB P06746 1/20 0.47
CHRM1 P11229 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ALOX12 P18054 1/20 0.44
CCR1 P32246 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29527101 0.82 POLB (0.66) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL3355665 0.82 POLB (0.66) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL22777312 0.81 ATF4 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL22777309 0.81 ATF4 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL22777311 0.81 ATF4 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL23908212 0.81 ATF4 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL22777541 0.81 ATF4 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL23908211 0.81 ATF4 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL21618321 0.76 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL24225653 0.75 CYP1A2 (0.74) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 CYP1A2 4440/4885CYP3A4 4341/4885CYP2C9 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.